Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 39 for “"Programmed Cell Death Ligand 1"”.

  1. Programmed cell death-ligand 1 (PD-L1) expression in HIV-associated diffuse large B-cell lymphoma – role and regulation

    Diffuse Large B cell Lymphoma (DLBCL) is an aggressive disease that displays striking heterogeneity at both the molecular and clinical levels; and as a result, up to 40% of patients relapse or are refractory to standard first-line therapy. DLBCL is the most common subtype of lymphoma affecting …

    cape-town Repository record for Programmed cell death-ligand 1 (PD-L1) expression in HIV-associated diffuse large B-cell lymphoma – role and regulation (opens in a new tab)

  2. Η έκφραση του συνδέτη του μορίου προγραμματισμένου κυτταρικού θανάτου PD-L1 (programmed cell death ligand-1) στον κολο-ορθικό καρκίνο

    … του προγραμματισμένου κυτταρικού θανάτου PD-1 (programmed cell death), ο συνδέτης του PD-L1 (PD ligand), η πρωτεΐνη 4 σχετιζόμενη με τα κυτταροτοξικά Τ-λεμφοκύτταρα CTLA4 (cytotoxic T-lymphocyte associated protein 4), το γονίδιο ενεργοποίησης των λεμφοκυττάρων LAG-3 (lymphocyte activation gene) …

    athens Repository record for Η έκφραση του συνδέτη του μορίου προγραμματισμένου κυτταρικού θανάτου PD-L1 (programmed cell death ligand-1) στον κολο-ορθικό καρκίνο (opens in a new tab)

  3. Modulations of Programmed Cell Death-Ligand 1 and Multidrug-Resistance Protein 5 in Triple-Negative Breast Cancer by Kānuka Leaf Extract

    … because they can simultaneously target cancer cell vulnerabilities and modulate the tumour immune microenvironment. Within this context, the present thesis provides the first comprehensive evaluation of Kunzea ericoides (kānuka) leaf extract as a potential anticancer and chemo sensitising agent …

    auckland-tech Repository record for Modulations of Programmed Cell Death-Ligand 1 and Multidrug-Resistance Protein 5 in Triple-Negative Breast Cancer by Kānuka Leaf Extract (opens in a new tab) Embargoed until 2029-08-31

  4. Exploring the Regulation of PD-L1 Expression as a Function of Stiffness via Mechanotransduction

    … is often characterized by an upregulation of programmed cell death ligand 1 (PD-L1) on its surface which aids cancer immune invasion and tumor progression. As the tumor progresses, it often has tissue stiffening which is linked with metastasis and poor patient outcome. Recent studies have …

    jhu Repository record for Exploring the Regulation of PD-L1 Expression as a Function of Stiffness via Mechanotransduction (opens in a new tab)

  5. Characterizing PD-L1-Targeting Extracellular Vesicles Produced by Oncolytic Vaccinia Virus Infection

    Tumour cells evade immune responses by multiple mechanisms in the tumour microenvironment, including through the expression of immunosuppressive molecules. The programmed cell death ligand 1 (PD-L1) plays a major role in this immunosuppression, and its expression is often up regulated as a result …

    ottawa-retro Repository record for Characterizing PD-L1-Targeting Extracellular Vesicles Produced by Oncolytic Vaccinia Virus Infection (opens in a new tab)

  6. The impact of the liver microenvironment on the immune checkpoint regulator PD-L1 in liver metastasis of pancreatic cancer

    … the 4th most common cause of cancer-related deaths. Lacking specific symptoms, PDAC is mostly diagnosed at a locally advanced or metastatic stage, with the liver representing the main site of metastases and hepatic myofibroblasts (HMF) playing a pivotal role in metastatic outgrowth. To date, …

    cau-kiel Repository record for The impact of the liver microenvironment on the immune checkpoint regulator PD-L1 in liver metastasis of pancreatic cancer (opens in a new tab)

  7. The Biological and Immunological Effects of Irreversible Electroporation and Combination Therapy Options for the Improving the Treatment of Pancreatic Cancer

    … electrical pulses to form microlesions in cell membranes and induce cell death. While IRE has had significant impact in pancreatic cancer treatment in clinical trials, little is known on the biological and immunological effects of IRE on pancreatic cancer. By studying the effects of IRE on …

    vt Repository record for The Biological and Immunological Effects of Irreversible Electroporation and Combination Therapy Options for the Improving the Treatment of Pancreatic Cancer (opens in a new tab)

  8. Rationally designing strategies to augment checkpoint therapy in cancer

    … focuses on designing a novel treatment for hepatocellular carcinoma (HCC), which is a type of primary liver cancer and is in the top 3 causes of cancer related deaths owing to most patients being diagnosed at advanced stage of the disease. This first research chapter uses reovirus, an oncolytic …

    birmingham Download PDF for Rationally designing strategies to augment checkpoint therapy in cancer (opens in a new tab)

  9. Multi-omics analysis and modelling of T cell immunity and interferon signalling pathways for engineered T cell therapy

    This thesis examines the nature of T cells through the lens of genomics. It delves into type I interferon (IFN)-mediated signalling in the tumour microenvironment (TME), focusing on the GMP-AMP synthase (cGAS)-stimulator of IFN genes (STING) pathway, and explores novel strategies to optimise T …

    oxford Repository record for Multi-omics analysis and modelling of T cell immunity and interferon signalling pathways for engineered T cell therapy (opens in a new tab)

  10. ELUCIDATING THE ROLE OF THE TYROSINE PHOSPHATASE, SHP-2, IN REGULATION OF PD-L1 EXPRESSION IN NON-SMALL LUNG CANCER USING BOTH BIOCHEMICAL ANALYSES AND REAL-WORLD GENOMIC INFORMATION

    … inhibitors (ICIs), especially those that target programmed cell death protein 1 (PD-1) and programmed cell death ligand-1 (PD-L1), have been shown to provide substantial clinical benefit in many patients with non-small cell lung cancer (NSCLC). While these therapeutic agents can be highly …

    uky-thes Repository record for ELUCIDATING THE ROLE OF THE TYROSINE PHOSPHATASE, SHP-2, IN REGULATION OF PD-L1 EXPRESSION IN NON-SMALL LUNG CANCER USING BOTH BIOCHEMICAL ANALYSES AND REAL-WORLD GENOMIC INFORMATION (opens in a new tab)

  11. Immunotherapy in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma: biological landscape and prognostic biomarkers to improve patients' stratification

    Head and neck squamous cell carcinoma (HNSCC) is the eight most frequent cancer in the world, and approximately 2/3 of the patients are diagnosed at locally advanced stages (stage III or IV). Despite improvements in HNSCC management and the aggressiveness of first-line curative treatment, 65% of …

    the-open-u Download PDF for Immunotherapy in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma: biological landscape and prognostic biomarkers to improve patients' stratification (opens in a new tab)

  12. Harnessing DNA nanoarchitecture to overcome immunoevasion in cancer

    … a patient’s own immune system to fight malignant cells. However, the clinical application of immunotherapy has been hindered by the immunosuppressive tumor microenvironment generated by cancer cells as a mechanism to impede immune function and evade immune detection. Clinically used …

    bu Repository record for Harnessing DNA nanoarchitecture to overcome immunoevasion in cancer (opens in a new tab)

  13. Resposta imune e mecanismos de evasão na carcinogênese de lábio: um estudo imunoistoquímico

    … recognize and destroy malignant or altered cells. However, through immunosuppressive strategies, such as the signaling pathways of the programmed cell death ligand-1 (PD-L1) and human leukocyte antigen-G (HLA-G), these mutated cells often escape the antitumor immune response. The aim of this …

    brazil-ufrn Repository record for Resposta imune e mecanismos de evasão na carcinogênese de lábio: um estudo imunoistoquímico (opens in a new tab)

Page 1 of 2